Butler John P.
SEC insider (Form 3/4/5 filer). CIK 0001591467. CEO and President at Akebia Therapeutics, Inc. (AKBA). 12 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in CAMBRIDGE, MA.
Companies Butler John P. has filed insider reports for
- Akebia Therapeutics, Inc. (AKBA): Director, Officer, CEO and President
Butler John P.
CIK: 0001591467
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Akebia Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Aug 6, 2026AKBA
Akebia Therapeutics, Inc.
ExerciseDirect350K shares at avg. $0.63$221K - Mar 4, 2026AKBA
Akebia Therapeutics, Inc.
PurchaseDirect69.3K shares at avg. $1.25$87K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
AwardDirect175.3K shares at avg. $1.41$247K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
SaleDirect114.9K shares at avg. $1.39$160K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
SaleDirect46.7K shares at avg. $1.39$65K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
SaleDirect83.7K shares at avg. $1.39$116K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
SaleDirect96.1K shares at avg. $1.39$134K - Jan 30, 2026AKBA
Akebia Therapeutics, Inc.
AwardDirect743K shares- - Mar 3, 2025AKBA
Akebia Therapeutics, Inc.
SaleDirect46.4K shares at avg. $1.83$85K - Feb 3, 2025AKBA
Akebia Therapeutics, Inc.
SaleDirect98K shares at avg. $2.10$206K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 | AKBA Akebia Therapeutics, Inc. | Exercise | 350,000 | $0.63 | $220,500 | Direct |
| Mar 4, 2026 | AKBA Akebia Therapeutics, Inc. | Purchase | 69,270 | $1.25 | $86,588 | Direct |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | Award | 175,250 | $1.41 | $247,103 | Direct |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | Sale | 114,891 | $1.39 | $159,698 | Direct |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | Sale | 46,660 | $1.39 | $64,857 | Direct |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | Sale | 83,689 | $1.39 | $116,328 | Direct |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | Sale | 96,065 | $1.39 | $133,530 | Direct |
| Jan 30, 2026 | AKBA Akebia Therapeutics, Inc. | Award | 743,000 | - | $0 | Direct |
| Mar 3, 2025 | AKBA Akebia Therapeutics, Inc. | Sale | 46,409 | $1.83 | $84,928 | Direct |
| Feb 3, 2025 | AKBA Akebia Therapeutics, Inc. | Sale | 97,982 | $2.10 | $205,762 | Direct |
1-10 of 12 transactions